Dr. Jennifer L. Raymond's lab at Stanford University focuses on understanding how learning influences brain function, particularly in the context of sensory processing and motor control. The lab investigates how the brain's neural circuits adapt their signal processing capabilities through experience, aiming to understand fundamental processes like synaptic plasticity that can lead to improved recovery from neural disorders. By combining experimental techniques with computational models, the lab seeks to reveal insights that could innovate clinical strategies for balancing and eye movement disorders.

Dr. Joo Eun Jung's lab focuses on understanding how aging affects brain injuries, specifically intracerebral hemorrhage (ICH). The research aims to identify how immune responses in the lungs, influenced by an age-related factor called CCL11, contribute to brain damage after a stroke. By exploring the role of immune cells in both the lung and brain, the lab hopes to find new treatment methods for elderly patients suffering from these conditions.

Dr. Giuseppe Tosto's lab at Columbia University focuses on understanding Alzheimer's disease, particularly within Hispanic/Latino populations. Acknowledging that these groups have a higher prevalence of Alzheimer's, the lab aims to enhance genetic research by sequencing the genomes of 6,000 individuals from diverse Hispanic backgrounds, especially those with significant Native American ancestry. This work will help in uncovering rare genetic variants associated with the disease and improving our understanding of Alzheimer's in underrepresented populations.

Dr. Jens H Jensen's lab focuses on developing advanced imaging techniques to better understand and monitor Alzheimer's disease. They use specialized MRI methods to evaluate how the disease progresses and how it responds to potential treatments in mouse models. By applying these methods, they hope to uncover new insights into Alzheimer's pathology and assist in the development of more effective therapies.

Dr. Ganesh M Babulal's lab focuses on understanding the risk factors for Alzheimer’s disease, particularly in African American populations. The research aims to identify how environmental, social, and psychological factors contribute to cognitive decline and the risk of Alzheimer’s. This is achieved by collaborating with community members and involving participants in comprehensive assessments over several years to gather vital data that can influence future treatments and interventions.

Dr. Henrieta Scholtzova's lab at NYU School of Medicine is focused on understanding how the immune system can be harnessed to tackle Alzheimer's disease, particularly through a unique approach using the TLR9 pathway. The lab uses squirrel monkeys, which develop age-related amyloid conditions similar to humans, to test new therapies aimed at improving cognitive function and preventing complications that often arise with current treatments. By integrating various biomarker data and advanced imaging techniques, they aim to better understand and treat cerebral amyloid angiopathy, a common risk factor for cognitive decline in Alzheimer's patients.

Dr. Patrick Hof's lab is focused on understanding how cardiovascular health impacts brain health as humans age, particularly in comparison with great apes like chimpanzees and gorillas. The research aims to uncover why humans are more prone to cognitive decline and specific heart diseases than our closest relatives. By studying the differences in brain and heart aging between these species, the lab hopes to provide insights into how we can promote healthier aging in humans.

Dr. H Branch Coslett's lab at the University of Pennsylvania focuses on improving language recovery in stroke patients suffering from aphasia. The lab explores the use of advanced brain stimulation techniques, like Transcranial Magnetic Stimulation (TMS), alongside speech therapy to enhance language function. Through careful study and modeling, they aim to identify the best treatment approaches and understand how they work at the brain level.

Dr. Devin L Brown's lab at the University of Michigan focuses on understanding how sleep apnea affects stroke patients, particularly the differences in how it manifests among various ethnic groups. By investigating the underlying causes of sleep apnea after a stroke, the lab aims to create personalized treatment plans that improve patient outcomes. This research is crucial because stroke can severely disrupt brain function, leading to high rates of sleep apnea in affected individuals, which is often overlooked in traditional care.

Dr. Yan Dong's lab focuses on understanding how specific brain cells, called astrocytes, influence behaviors related to cocaine addiction. They examine how cocaine changes the connectivity in certain brain regions, particularly how these changes can lead to cravings and relapse. By studying these processes, the lab aims to uncover potential new treatment strategies for dealing with addiction.

Dr. Karen L. Pierce's lab at UC San Diego focuses on improving the early detection of Autism Spectrum Disorder (ASD) using innovative eye-tracking technology. By analyzing visual attention patterns in toddlers, the lab aims to enhance the accuracy of ASD screenings during routine pediatric check-ups. Their research not only tests the effectiveness of eye tracking as a reliable screening tool but also explores how it compares to traditional parent questionnaire methods in identifying children who may need further evaluation.

Dr. Ai Yamamoto's lab at Columbia University focuses on understanding and addressing neurodegenerative diseases such as Parkinson's and Alzheimer's. The research primarily investigates the role of autophagy, a key cellular process that cleans out damaged components in neurons, and how its dysfunction contributes to these diseases. By examining specific cellular pathways, including calcium signaling and the role of certain proteins, the lab aims to identify potential therapeutic targets to treat these debilitating conditions.

Dr. Zhenyu Yue's lab at the Icahn School of Medicine focuses on understanding how autophagy helps protect neurons in the brain. They study how the process of autophagy, which recycles damaged cellular components, can go wrong in diseases like Alzheimer's and Parkinson's. The lab aims to discover ways to improve neuroprotection through understanding these mechanisms, potentially leading to new treatments for neurodegenerative diseases.

Dr. Greg J. Bashaw's lab studies how neurons form connections in the brain and spinal cord, focusing on a specific receptor that guides the growth of nerve fibers. By investigating the mechanisms of this receptor, the lab aims to uncover insights into developmental disorders and potential treatments for nerve damage. Their research could contribute to a better understanding of how the nervous system develops and heals after injury.

Dr. Boon Lead Tee's lab at UCSF focuses on understanding how bilingualism impacts cognitive health, particularly in relation to Alzheimer's disease and related dementias. By studying diverse populations across multiple cultures and languages, the lab aims to uncover the ways bilingual experiences may contribute to cognitive resilience and longevity. This interdisciplinary approach combines neuroimaging, behavioral assessments, and social factors to better understand the complex relationships between language, cognition, and health.

Dr. Jack Feldman's lab at UCLA focuses on understanding how the brain controls breathing and how this relates to emotional regulation. They conduct experiments in both living and lab-based settings to uncover the mechanisms behind respiratory patterns and their effects on emotional states such as anxiety and panic. This research has significant implications for improving treatments for conditions related to breathing disorders and emotional disturbances.

Dr. Kuan-Hua Chen's lab at the University of Nebraska Medical Center focuses on Alzheimer's disease and how relationships with family members, especially spouses, can impact the disease's progression. They study how connectedness between patients and their caregivers might slow down the early stages of Alzheimer's. The lab employs various methods, including observations, wearable technologies, and interviews, to gain insights into these dynamics.

Dr. Christopher G. Favilla's lab focuses on improving outcomes for stroke patients and individuals with heart failure. They are developing innovative educational tools and monitoring techniques to enhance patient care, especially regarding stroke awareness and management. Their research includes exploring the effects of heart devices on brain health and creating personalized video education platforms to empower patients and caregivers post-stroke.

Dr. Soojin Park's lab at Columbia University Health Sciences focuses on improving the management of patients suffering from acute hydrocephalus and delayed cerebral ischemia, particularly after brain injuries like subarachnoid hemorrhages. The lab leverages machine learning and artificial intelligence to develop predictive models that help identify complications early, aiming to reduce hospital stays and improve patient outcomes. Research utilizes data from patient monitoring to enhance decision-making processes in critical care settings.

Dr. Manu Sharma's lab focuses on understanding the role of molecular chaperones in regulating tau protein levels and preventing the aggregation seen in neurodegenerative diseases such as Alzheimer's. By investigating how these chaperones and their complexes interact with tau, the lab aims to identify potential targets for therapeutic intervention. Using a combination of in vitro neuron models and in vivo mouse models, the lab seeks to uncover new mechanisms that could contribute to tackling the tauopathies associated with aging populations.